Hidrosefalus

01Pathophysiology

The brain normally produces approximately 500 mL of cerebrospinal fluid (CSF) per day through the choroid plexus, primarily located in the lateral, third, and fourth ventricles. At any given time, only about 150 mL of CSF circulates within the ventricular system and subarachnoid space. CSF flows from the lateral ventricles through the foramina of Monro into the third ventricle, then through the aqueduct of Sylvius into the fourth ventricle, exiting via the foramina of Luschka (lateral) and foramen of Magendie (midline) into the subarachnoid space. Absorption occurs at the arachnoid granulations (also called arachnoid villi), which drain into the dural venous sinuses, predominantly the superior sagittal sinus.

Hydrocephalus develops when there is a mismatch between CSF production and absorption, or when there is obstruction of the normal flow pathways. This leads to progressive ventricular dilation and increased intracranial pressure (ICP). The elevated ICP is directly responsible for the clinical symptoms: headache from stretching of pain-sensitive meningeal structures, nausea and vomiting from pressure on the area postrema in the floor of the fourth ventricle, and papilledema from transmission of elevated pressure along the optic nerve sheath. CN VI palsy is a classic "false localizing sign" because the abducens nerve has the longest intracranial course and is vulnerable to compression against the petrous bone when ICP rises diffusely.

In infants, the open fontanelles and unfused cranial sutures allow the skull to expand, which is why the classic presentation is a rapidly increasing head circumference with a bulging anterior fontanelle rather than the headache and papilledema seen in older patients. The "sunset sign" (tonic downward deviation of the eyes) results from pressure on the tectal plate of the midbrain, which houses the vertical gaze center. This is essentially a form of Parinaud syndrome caused by dorsal midbrain compression.

In Normal Pressure Hydrocephalus (NPH), the pathophysiology is distinct. The ventricles are chronically enlarged, but the CSF pressure measured on lumbar puncture is within the normal range (hence the name). The prevailing theory is that intermittent pressure waves (B-waves) cause progressive ventricular dilation over time, even though the baseline pressure normalizes between episodes. The periventricular white matter, particularly around the frontal horns, is compressed and becomes edematous. This damages the corona radiata motor fibers to the legs (which lie medially, as predicted by the motor homunculus), producing the characteristic gait apraxia. Frontal lobe dysfunction accounts for the dementia, and disruption of periventricular pathways to the sacral micturition center causes urge incontinence.

A frequently tested concept is ex vacuo ventriculomegaly, which must be distinguished from true hydrocephalus. In neurodegenerative diseases such as Alzheimer disease or frontotemporal dementia, brain parenchyma atrophies and the ventricles passively enlarge to fill the space. There is no increase in ICP, and crucially, the sulci are proportionally enlarged alongside the ventricles. This is not hydrocephalus and does not require shunting.

02Classification and Clinical Manifestation

Classification by Mechanism

Clinical Manifestation by Age Group

NPH: Order of Symptom Appearance and Response to Treatment

This pattern is extremely testable. The gait disturbance in NPH is both the earliest manifestation and the best predictor of shunt responsiveness.

03Diagnostic Workup

CT Head is the best initial test in any patient presenting with signs of elevated ICP, including suspected hydrocephalus. It is fast, widely available, and reliably shows ventricular dilation. The Evans index is calculated as the ratio of the maximum width of the frontal horns to the maximum internal diameter of the skull at the same level. A value greater than 0.3 is diagnostic of ventriculomegaly. On CT, you should also look for periventricular hypodensity (transependymal flow of CSF), which indicates active hydrocephalus with elevated pressure, as opposed to stable or compensated ventriculomegaly.

A critical distinction on imaging is differentiating true hydrocephalus from ex vacuo ventriculomegaly. In true hydrocephalus, the ventricles are dilated but the cerebral sulci are effaced or small because pressure is pushing brain tissue outward against the skull. In ex vacuo change, both the ventricles and sulci are enlarged proportionally because brain tissue has been lost.

MRI Brain is ordered after CT when you need to define the cause of hydrocephalus, particularly in non-communicating (obstructive) types. MRI can identify the exact point of obstruction: aqueductal stenosis will show a dilated third ventricle and lateral ventricles with a normal-sized fourth ventricle, while a posterior fossa tumor will show a mass compressing the fourth ventricle. Cine MRI (phase-contrast MRI) can assess CSF flow dynamics at the aqueduct, which is especially useful in planning endoscopic third ventriculostomy.

In neonates, cranial ultrasound through the anterior fontanelle is the preferred first-line study because it avoids radiation and sedation. It is the standard tool for screening premature infants for intraventricular hemorrhage (IVH) and monitoring post-hemorrhagic hydrocephalus.

For NPH, the diagnostic approach centers on demonstrating that the ventriculomegaly is responsible for the symptoms and that symptoms improve with CSF drainage. The large-volume lumbar puncture ("tap test") involves removing 30 to 50 mL of CSF and then reassessing the patient's gait before and after. Improvement in gait strongly predicts a good response to VP shunt placement. Importantly, a negative tap test does not rule out NPH; some patients with NPH will not improve with a single tap but will still respond to shunting. If the tap test is equivocal, continuous lumbar CSF drainage over 48 to 72 hours or continuous ICP monitoring looking for B-waves can be pursued.

04Management and Treatment

Acute Management: When a patient presents with acute hydrocephalus and signs of elevated ICP (declining consciousness, Cushing triad, or imaging showing impending herniation), the next best step is emergent EVD placement. This is a bedside neurosurgical procedure that allows immediate CSF drainage and continuous ICP monitoring. It is not a permanent solution. Patients are typically positioned with the head of bed elevated to 30 degrees. The EVD is kept at a set height above the external auditory meatus to regulate drainage.

VP Shunt Placement is the definitive treatment for most forms of hydrocephalus. A proximal catheter is placed in the lateral ventricle (usually the right, through a frontal or occipital burr hole), connected to a one-way valve that opens at a set pressure threshold, and a distal catheter is tunneled subcutaneously to the peritoneal cavity where the CSF is absorbed. Alternative distal sites include the right atrium (ventriculoatrial or VA shunt) or the pleural space, but these are second-line options used when the peritoneum is not suitable (e.g., after extensive abdominal surgery or peritonitis).

VP Shunt Complications

Endoscopic Third Ventriculostomy (ETV) is the preferred treatment for obstructive hydrocephalus caused by aqueductal stenosis or posterior fossa tumors. It creates a fenestration in the floor of the third ventricle, allowing CSF to bypass the obstruction and flow directly into the prepontine cistern. The advantage is that it avoids lifelong shunt dependency. It is most effective in patients older than 6 months with non-communicating hydrocephalus. It is not effective for communicating hydrocephalus, because the problem in communicating hydrocephalus is absorption, not obstruction.

NPH Management: After a positive large-volume LP trial demonstrating gait improvement, the patient is referred for VP shunt placement with an adjustable-pressure valve. The adjustable valve allows postoperative fine-tuning to balance adequate drainage against the risk of over-drainage and subdural hematoma. Patients should be counseled that gait is the symptom most likely to improve, while dementia, particularly if present for a long time, may not improve.

Acetazolamide reduces CSF production by inhibiting carbonic anhydrase in the choroid plexus. It is used as a temporary measure, particularly in premature neonates with post-hemorrhagic hydrocephalus who are too small or too unstable for shunt surgery. The typical starting dose is 25 mg/kg/day, which can be increased to 100 mg/kg/day. Side effects include metabolic acidosis and electrolyte disturbances. It is not a substitute for surgical intervention in progressive hydrocephalus.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The single most common trap with hydrocephalus questions involves Normal Pressure Hydrocephalus. Students often miss the diagnosis because the word "normal pressure" is confusing: they assume that if ICP is normal, the patient cannot have hydrocephalus. The key is to recognize the clinical triad ("wet, wacky, and wobbly") in an elderly patient with ventriculomegaly on imaging and to know that the tap test (large-volume LP with gait reassessment) is the diagnostic maneuver.

A second major trap is the ex vacuo distractor. A vignette will present an elderly patient with dementia and imaging showing "enlarged ventricles," leading students to choose hydrocephalus. The discriminator is whether the sulci are enlarged proportionally. If sulci are widened alongside the ventricles, this is brain atrophy, not hydrocephalus, and no shunting is needed.

Another frequently tested concept is the order of symptom appearance and treatment response in NPH. Students who remember the triad but not the sequence will miss questions asking which symptom appears first (gait) or which improves most with shunting (gait). Dementia that has been present for years is less likely to improve with shunt placement, and this is often the tested nuance.

In pediatric vignettes, the trap is recognizing hydrocephalus in an infant. The vignette will describe an infant with an enlarging head, bulging fontanelle, and "downward gaze deviation" (sunset sign). Students sometimes mistake this for a seizure presentation or a craniosynostosis vignette. The key difference is that craniosynostosis presents with an abnormally shaped head (due to premature closure of sutures) but a normal or small fontanelle, whereas hydrocephalus presents with a uniformly enlarged head with a bulging, tense fontanelle and separated sutures.

Finally, shunt complications are a favorite testing topic. Students should know that the most common organism in VP shunt infection is Staphylococcus epidermidis (not S. aureus), and the management requires complete shunt removal (not just antibiotics alone). Over-drainage causing subdural hematoma is another tested complication, particularly in elderly patients whose bridging veins are already stretched due to brain atrophy.

The core competency being tested across hydrocephalus questions is the ability to integrate clinical presentation, imaging findings, and patient demographics to arrive at the correct diagnosis and then select the appropriate next step in management. Whether it is recognizing the NPH triad, distinguishing communicating from non-communicating types based on which ventricles are dilated, or knowing when to place an EVD versus a VP shunt versus an ETV, exam questions in this domain reward systematic clinical reasoning over rote memorization.